ProQR Therapeutics N.V. (PRQR)
NASDAQ: PRQR · Real-Time Price · USD
1.530
-0.035 (-2.24%)
At close: Jun 26, 2026, 4:00 PM EDT
1.559
+0.029 (1.87%)
After-hours: Jun 26, 2026, 7:29 PM EDT
ProQR Therapeutics Employees
ProQR Therapeutics had 187 employees as of December 31, 2025. The number of employees increased by 21 or 12.34% compared to the previous year.
Employees
187
Change (1Y)
21
Growth (1Y)
12.34%
Revenue / Employee
$84,276
Profits / Employee
-$281,071
Market Cap
161.20M
Employees Chart
Related Stocks
| Company Name | Employees |
|---|---|
| Humacyte | 184 |
| Innate Pharma | 164 |
| Caribou Biosciences | 97 |
| Tenaya Therapeutics | 70 |
| Acumen Pharmaceuticals | 61 |
| Pyxis Oncology | 56 |
| OnKure Therapeutics | 45 |
| Milestone Pharmaceuticals | 38 |
PRQR News
- 2 days ago - ProQR Therapeutics price target lowered to $10 from $14 at Raymond James - TheFly
- 2 days ago - ProQR Therapeutics price target lowered to $10 from $11 at JonesResearch - TheFly
- 2 days ago - ProQR Therapeutics price target lowered to $3 from $4 at Chardan - TheFly
- 3 days ago - ProQR Therapeutics Slides: Conference presentation - Filings
- 3 days ago - ProQR Therapeutics prices 27.62M shares at $1.81 in registered direct offering - TheFly
- 3 days ago - ProQR Therapeutics announces positive Phase 1 data for AX-0810 - TheFly
- 3 days ago - ProQR Prices $50.0 Million Underwritten Registered Direct Offering and Concurrent Private Placement - GlobeNewsWire
- 3 days ago - ProQR Announces Positive Phase 1 Target Engagement Data for AX-0810, Establishing First Clinical Validation of the Axiomer RNA Editing Platform - GlobeNewsWire